Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 141 | PRTA | PROTHENA CORP PLC | Healthcare | 39,660.0 | $388K | 0.09% | +13K | +50.7% | $9.79 | -11.0% |
| 142 | TYRA | TYRA BIOSCIENCES INC | Healthcare | 12,123.0 | $387K | 0.09% | +74.0 | +0.6% | $31.94 | -18.5% |
| 143 | BEAM | BEAM THERAPEUTICS INC | Healthcare | 11,272.0 | $387K | 0.09% | +1K | +13.1% | $34.32 | -22.6% |
| 144 | CELC | CELCUITY INC | Healthcare | 3,695.0 | $387K | 0.09% | +1K | +42.7% | $104.62 | -10.9% |
| 145 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 5,510.0 | $385K | 0.09% | +526.0 | +10.6% | $69.81 | +5.5% |
| 146 | SVRA | SAVARA INC | Healthcare | 62,205.0 | $383K | 0.09% | +23K | +57.9% | $6.16 | -12.8% |
| 147 | COGT | COGENT BIOSCIENCES INC | Healthcare | 9,885.0 | $383K | 0.09% | +3K | +52.6% | $38.70 | -3.4% |
| 148 | RXRX | RECURSION PHARMACEUTICALS IN | Healthcare | 103,872.0 | $381K | 0.09% | +41K | +64.9% | $3.67 | -15.8% |
| 149 | ALT | ALTIMMUNE INC | Healthcare | 125,363.0 | $381K | 0.09% | +74K | +142.3% | $3.04 | -2.3% |
| 150 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 6,281.0 | $379K | 0.09% | +93.0 | +1.5% | $60.36 | +4.7% |
| 151 | IMNM | IMMUNOME INC | Healthcare | 17,802.0 | $377K | 0.09% | +4K | +27.8% | $21.19 | +30.1% |
| 152 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 13,853.0 | $374K | 0.09% | +6K | +87.5% | $26.98 | -1.4% |
| 153 | — | UPSTREAM BIO INC | — | 53,638.0 | $371K | 0.09% | +44K | +433.9% | $6.92 | — |
| 154 | IVVD | INVIVYD INC | Healthcare | 424,933.0 | $371K | 0.09% | +307K | +261.5% | $0.87 | -0.5% |
| 155 | JANX | JANUX THERAPEUTICS INC | Healthcare | 24,130.0 | $371K | 0.09% | +6K | +35.4% | $15.36 | +10.4% |
| 156 | ABUS | ARBUTUS BIOPHARMA CORP | Healthcare | 76,807.0 | $369K | 0.09% | +19K | +32.7% | $4.80 | +0.8% |
| 157 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 20,012.0 | $368K | 0.09% | +12K | +137.1% | $18.37 | +30.3% |
| 158 | BLTE | BELITE BIO INC | Healthcare | 2,369.0 | $365K | 0.09% | +440.0 | +22.8% | $153.98 | +5.6% |
| 159 | — | NEWAMSTERDAM PHARMA COMPANY | — | 10,763.0 | $365K | 0.09% | +3K | +47.1% | $33.89 | — |
| 160 | EYPT | EYEPOINT INC | Healthcare | 25,111.0 | $359K | 0.08% | +8K | +47.3% | $14.30 | -61.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
36.7%
Technology
15.7%
Financial Services
15.3%
Industrials
13.0%
Consumer Cyclical
5.8%
Energy
4.7%
Real Estate
2.8%
Utilities
1.7%
Communication Services
1.7%
Basic Materials
1.5%